这个不好说，因为我们还没有用过，但是看试验数据来说是比较安全的，致死性

This is hard to say, because we have not used it yet, but it is relatively safe from the test data. The incidence of fatal infections has not increased, but all immunosuppressants have not increased in the evidence-based medicine evidence, but In fact, lethal infections occur in clinical work. So in this point, let me evaluate this drug. We have not used it yet. It is difficult to say whether there will be some very serious infections or adverse reactions, but based on the fact that we used traditional immunosuppressants or targeted drugs before All have had severe, life-threatening infections.

That's not good, because we haven't used it yet, but it's safe to look at the trial data, the rate of fatal infections hasn't increased, but all immunosuppressants haven't increased in evidence-based medical evidence, but in fact fatal infections are found in clinical work. So let me evaluate this drug, we haven't used it yet, it's hard to say if there will be some very serious infections or adverse reactions, but based on the fact that we've had life-threatening, serious infections in the past with both traditional immunosuppressants and targeted drugs.

It's hard to say, because we haven't used it yet, but it's relatively safe to look at the experimental data. The incidence of fatal infections has not increased, but all immunosuppressants have not increased in evidence-based medicine, but in fact, fatal infections will be found in clinical work. So let me evaluate this drug. We haven't used it yet. It's hard to say whether there will be some very serious infections or adverse reactions. But based on the fact that we have had serious life-threatening infections with both traditional immunosuppressants and targeted drugs before.